Topics

Articles

Bloomberg BusinessWeek rakes over charitable copay programs

PhRMA-sponsored study outlines the economic effects of US-based operations

Deals with Amgen and Sanofi/Regeneron enhance new pricing policies for specialty drugs

Managed care organizations are adjusting rapidly to onslaught of specialty products

The SP channel continues to grow, with manufacturers looking for more control over access

Both clinical research and commercial analytics markets to be served by combination

More healthcare stakeholders line up against the industry

Better access to hospital systems is a goal; pharmaceutical business is fading

Double-digit growth (12.2%) for the second year running